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Renal tubular transport of gentamicin in the rat. The renal han-
dling of gentamicin in the rat was examined by clearance, micro-
injection, and renal cortical-slice techniques. The steady-state
renal clearance of 4C-gentamicin, when corrected for the 7.5%
binding to plasma protein, was not significantly different from
that of 3H-inulin. At the end of the renal clearance experiments,
the cortical concentration of gentamicin was 93 7gIg of tissue(N = 7), a concentration threefold greater than that of the me-
dulla and 20-fold greater than that of serum. Absorption of 3H-
gentamicin along the proximal convoluted tubule and loop of
1—Tenle was demonstrated by the tubular microinjection tech-
nique. No reabsorption of 3H-gentamicin was detected beyond
the early distal convoluted tubule. The tubular absorption of 3H-
gentamicin was load dependent. Fractional absorption of 3H-gen-
tamicin averaged 30.1 2.7% when the dose of H-gentamicin
injected into early proximal tubular convolutions averaged 132
17 pg. It was decreased to 13.6 2.6% when the microinjected
dose of gentamicin was increased to 1996 388 pg. No evidence
of transtubular absorption of 3H-gentamicin was detected during
the microinjection experiments. Microperfusion of peritubular
capillaries failed to demonstrate urinary precession of 3H-gen-
tamicin over "C-inulin, a finding which argues against a rapid
transtubular secretory flux of gentamicin. Significant uptake of
gentamicin was demonstrated by renal cortical slices incubated
in medium containing '4C-gentamicin. The accumulation of '4C-
gentamicin by renal cortical slices was not inhibited by probene-
cid or N'-methylnicotinamide but was inhibited by netilmicin and
tobramycin. These data support the conclusion that the renal ac-
cumulation of gentamicin reflects transport of gentamicin across
both the apical and basolateral membranes of proximal tubular
epithelium.
Transport tubulaire de Ia gentamicine chez le rat. Le transport
tubulaire de la gentamicine chez Ic rat a etC CtudiC au moyen des
techniques de clearance, de micro-injection et de tranches de
cortex. La clearance de Ia '4C-gentamicine a l'état stationnaire,
corrigee pour Ia liaison aux proteines plasmatiques de 7,5%,
n'est pas significativement différente de celle de l'inuline. A Ia
fin des experiences de clearances Ia concentration corticale de Ia
gentamicine est de 93 7 p.glg de tissu (N = 7), trois fois plus
que dans Ia mCdullaire et vingt fois plus que dans le plasma.
L'absorption de gentamicine tritiCe Ic long du tube contourné
proximal et dans l'anse de Henle a pu étre démontrée par Ia tech-
nique de microinjections tubulaires. Aucune reabsorption de
gentamicine tritiée na été constatCe en aval du tube contourné
distal initial. Cette absorption tubulaire est dépendante de Ia
Received for publication September 6, 1978
and in revised form January 31, 1979
0085-2538/79/0016-0440 $02.20
© 1979 by the International Society of Nephrology
440
charge. L'absorption fractionnelle de gentamicine tritiCe est en
moyenne de 30,1 2,7% quand Ia quantitC injectee dans le tube
proximal prCcoce est de 132 17 pg. Elle diminue a 13,6 2,6%
quand Ia quantitC injectee augmente a 1996 388 pg. Aucune
preuve de passage transtubulaire de gentamicine tritiEe na été
obtenue au cours des experiences de microinjections. La micro-
perfusion des capillaires péritubulaires n'a pas permis de mettre
en evidence une precession de la gentamicine tritiCe sur l'inuline
14C, une constatation qui plaide contre un flux secrétoire trans-
tubulaire rapide. line captation significative de gentamicine a etC
mise en evidence par I'incubation de tranches de cortex dans un
milieu contenant de Ia gentamicine 14C. L'accumulation de 14C-
gentamicine par les tranches de cortex renal n'est pas inhibCe
par le probCnecid ou le N'-méthylnicotinamide mais lest par Ia
netilmycine et Ia tobramycine. Ces observations sont en faveur
du fait que l'accumulation rCnale de gentamicine reflète son
transport a Ia fois a travers Ia membrane apicale et Ia membrane
basolaterale de l'epithClium tubulaire proximal.
It is well established that gentamicin accumulates
within the kidney of man [1, 2] and experimental
animals [3-81 and that within the kidney gentamicin
is concentrated to a greater extent within the renal
cortex than in the medulla [4—6, 8]. In several stud-
ies, gentamicin has been localized within renal
proximal tubular epithelium [9-li]. That gentamicin
causes proximal tubular cell dysfunction and necro-
sis [8, 12—17] suggests a causal relationship between
the accumulation of gentamicin within proximal
tubular cells and the subsequent development of
gentamicin nephrotoxicity.
The route and mechanism by which gentamicin
gains access into proximal tubular epithelium re-
mains to be established. Nor is it clear which neph-
ron segments in addition to the proximal tubule ac-
cumulate gentamicin. On the basis of clearance
studies in man [18—20] and experimental animals [5,
21], investigators have concluded that gentamicin is
excreted primarily by glomerular filtration. Tubular
absorption of gentamicin has been inferred in some
studies by the finding that the clearance of gen-
tamicin was significantly less than the GFR [5, 19,
20]; the extent of tubular absorption, however, re-
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mains uncertain because binding of gentamicin to
plasma protein was not determined. If 20 to 30% of
gentamicin were bound to plasma protein, as re-
cently reported by Meyers et al [22], then these
clearance studies would suggest either no net tubu-
lar absorption [5, 19] or even net tubular secretion
of gentamicin [18, 21]. Evidence of gentamicin
transport across the apical membrane of proximal
tubular cells has been obtained by autoradiographic
techniques [9, 11]. These techniques, however, pro-
vide limited information concerning the amount of
gentamicin transported. That gentamicin may be
transported across the basolateral membrane of
proximal tubular epithelium is suggested by in vitro
studies of gentamicin uptake by rat renal cortical
slices [23].
In the present study we used renal clearance, mi-
croinjection, and renal cortical slice techniques in
an attempt to further define and clarify the renal
handling of gentamicin.
Methods
Studies were performed in female Sprague-Daw-
ley rats, weighing between 180 and 230 g, anesthe-
tized with sodium pentobarbital (50 mg/kg body wt,
i.p.).
Clearance studies. In seven rats, the renal clear-
ances of '4C-gentarnicin and H-inulin were deter-
mined. Polyethylene catheters were secured in a ca-
rotid artery, a jugular vein, and the urinary bladder
to permit monitoring of arterial blood pressure, in-
fusion of solutions, and the collection of urine sam-
ples, respectively. A solution of 0.9% sodium chlo-
ride to which was added '4C-gentamicin (specific ac-
tivity, 0.789 MCi/mg; Schering Corp., Bloomfield,
New Jersey) and 3H-inulin (specific activity, 680
/LCi/mg, New England Nuclear Corp., Boston,
Massachusetts) was infused at 0.22 mllmin into an
external jugular vein. Sixty minutes later, urine was
collected under oil in tared vials during four con-
secutive 20-mm periods. Blood samples were col-
lected from the tail vein at the midpoint of each pe-
riod. Aliquots of urine and plasma were pipetted in-
to Biofluor (New England Nuclear Corp.), and
radioactivity was assayed in a liquid scintillation
spectrometer.
Renal tissue concentration of '4C-gentamicin. At
the termination of clearance studies, the rats were
exsanguinated from the aorta, and the kidneys were
flushed in situ with 10 ml of ice-cold 0.9% sodium
chloride. The kidneys were removed, and cortex
and medulla were dissected free. The cortical and
medullary tissues were weighed and then homoge-
nized in 0.1 M sodium phosphate (pH, 8.0) at a vol-
ume-to-weight ratio of 4:1. The homogenate was
centrifuged at x27000g for 15 mm, and 100 p.l of
supernatant were added to I ml of tissue solubilizer
(Protosol, New England Nuclear Corp.), heated to
50° C for 4 hours, and then counted in a solution of
toluene and Omnifluor (New England Nuclear
Corp.). The quantity of gentamicin within cells or
bound to cell membranes was estimated by sub-
stracting from the total tissue content of gentamicin
that quantity present in the inulin space.
Serum protein binding of gentamicin. Cold gen-
tamicin together with trace amounts of 3H-gen-
tamicin (specific activity, 711 CiJmg; Amersham-
Searle Corp., Arlington Heights, Illinois) was added
to pooled rat serum to achieve a concentration of 5
g of base per milliliter. The pH of the serum was
adjusted to 7.4. Ten milliliters were placed in an
Amicon filter and allowed to equilibrate with the
PM-lO membrane for 45 mm at room temperature
before initiating ultrafiltration. Aliquots of serum
and filtrate were added to Biofluor and assayed for
radioactivity with appropriate corrections made for
quenching. In a second series of experiments, equi-
librium dialysis was performed by placing 1 ml of
pooled rat serum (pH, 7.4) containing 3H-gen-
tamicin (5 g of base/mi) into a dialysis bag and dia-
lyzing against 3 ml of Ringer's solution (pH, 7.4)
containing magnesium chloride, 1.5 mEq/liter, and
calcium chloride, 3.5 mEq/liter, for 24 hours at
37° C.1 Aliquots of serum and dialysate were added
to Biofluor and assayed for radioactivity. The per-
centage of unbound or free gentamicin was calcu-
lated by dividing the concentration of gentamicin in
filtrate or dialysate by the simultaneously deter-
mined concentration of gentamicin in serum.
Micropuncture experiments. Rats were prepared
for micropuncture of the kidney as previously de-
scribed [24]. Early proximal, late proximal, and
early distal tubular convolutions were identified by
bolus injections of FD&C green dye. Transit time of
the dye was 2.3 0.2 sec to early proximal, 12.2
0.7 sec to late proximal, and 39.0 1.5 sec to early
distal tubular convolutions. Microinjections were
not performed until 60 to 90 mm had elapsed follow-
ing the last injection of dye. Constriction pipettes
with outer tip diameters of 6 to 7 m were used for
Because an inverse relationship between the concentrations
of ionized calcium and magnesium and protein binding of gen-
tamicin has been identified (see Ref. 22), we performed the dial-
ysis equilibration studies under physiologic concentrations of
these ions.
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the intratubular injection of a 0.9% sodium chloride
solution containing different concentrations of 3H-
gentamicin and trace quantities of 14C-inulin (New
England Nuclear Corp.) and stained with FD&C
green dye. Microinjections were considered techni-
cally satisfactory if the injection rate, as visually es-
timated by the intratubular flow of the stained solu-
tion, was constant with no evidence of retrograde
flow beyond the puncture site. Injection rates were
8.6 1.2 nllmin in early proximal, 8.1 1.2 nhlmin
in late proximal, and 5.0 0.9 nllmin in early distal
tubular convolutions. Immediately following each
microinjection, three consecutive 4-mm urine sam-
ples were collected in scintillation vials containing
10 ml of PCS (Amersham-Searle Corp.) and 1 ml of
deionized water. Within this time interval, the re-
covery of 14C-inulin was essentially complete, and
the counts detected in the 3H channel had declined
to background levels. Additional urine collections
of the same duration were also obtained before each
intratubular injection to ensure that radioactivity
had returned to control values. Volumes of radio-
active solution identical to those injected into tu-
bules were added to control 4-mm urine collections
and used as a standard for the calculation of isotope
recovery. Only those microinjections in which the
14Cinulin recovery was 100 6% of the amount in-
jected were used.
Intratubular microinjection studies were per-
formed in three groups of rats. In group 1, micro-
injections of early proximal, late proximal, and
early distal tubular convolutions were performed
with 20- to 30-nl volume pipettes containing 132
(sEM) 17 pg of gentamicin base (5.6 pg/nl). In some
rats, microinjections were performed in early and
late proximal tubular convolutions of the same
nephron. During microinjection in an early proxi-
mal tubular convolution, the late proximal tubular
convolution of the same nephron was identified,
and a microinjection was performed at this site 30
mm after completion of the early proximal tubular
microinjection.
In group 2, microinjections of early proximal
tubular convolutions were performed with 30- to 40-
nl volume pipettes containing 1996 388 pg of gen-
tamicin base (64 pg/nl), and urine was collected for
48 mm. In some nephrons 24 mm after completing
the microinjection, the same site was reentered, and
unlabeled gentamicin in a dose approximately two-
fold that of 3H-gentamicin was injected. Urine col-
lections were continued for an additional 24 mm to
determine the effect of cold gentamicin on the re-
covery of 3H-gentamicin.
In group 3, peritubular capillary microinjections
were performed using constriction micropipettes
holding 50 to 70 ni. A solution containing 3H-gen-
tamicin at a concentration of 200 pglnl and 14C-in-
ulin was injected into "star vessels" at 102 12 nh
mm. At the start of the capillary injection, urine was
collected at 30-sec intervals for 4 mm and sub-
sequently at 4-mm intervals for an additional 20
mm.
Recoveries of 3H-gentamicin and 14C-inulin were
expressed as a percent of the amount injected. Re-
covery of 3H-gentamicin was further expressed as a
percent of the corresponding '4C-inulin recovery.
Proximal tubule is here defined as the portion of
the nephron between the early proximal and late
proximal tubular puncture sites. The loop of Henle
is defined as the segment between the late proximal
tubule and the earliest distal tubular segment acces-
sible to micropuncture. Absorption of gentamicin
was calculated at each micropuncture site as the dif-
ference between the amount of gentamicin injected
and that recovered in the urine.
Uptake of gentamicin by rat renal cortical slices.
Rat renal cortical slices were obtained with a
Stadie-Riggs microtome as previously described
[12]. Approximately 100 mg of tissue were placed in
incubation flasks containing 5 ml of medium with
the following composition in millimoles per liter: so-
dium, 140; potassium, 10; calcium, I; acetate, 10;
chloride, 136; phosphate, 2.4. The pH of the medi-
um was adjusted to 7.4 with 0.1 N sodium hydrox-
ide. Flasks were kept in ice until the time of in-
cubation, which began with the addition of 14C-gen-
tamicin to achieve concentrations of 1.8 x 10 mM,
3.6 X l0 mM, 3.6 x 10-2 m, and 3.6 X 10_i mi.
Incubation was performed in a Dubnoff metabolic
shaker for 120 mm at 28° C in an atmosphere of
100% oxygen. In four experiments, the tissue was
removed from the original medium and placed in
fresh medium free of gentamicin and incubated for
an additional 30 mm to determine whether 14C-gen-
tamicin would efflux from the tissue into the medi-
um. In other experiments, we examined the effect
of adding probenecid, N'-methylnicotinamide
(NMN), netilmicin, or tobramycin on the uptake of
i4Cgentammcin by renal cortical slices. At the end of
the incubation period, the tissue was blotted,
weighed, and placed in counting vials containing 1
ml of Protosol. The vials were incubated at 50° C
for approximately 12 hours, after which 100 l of
hydrogen peroxide were added, and the vials were
incubated for an additional 30 mm at 50° C. Then,
10 ml of toluene containing Omnifluor, 5 g/liter,
Tubular transport of gentamicin 443
were added to the vials, and the samples were as-
sayed for radioactivity.
After making appropriate corrections for quench-
ing, the uptake of gentamicin in tissue was calcu-
lated by substracting the amount of gentamicin in
extracellular fluid from the total tissue content of
gentamicin, expressed as micrograms per gram of
wet tissue weight. In previous studies [12], we de-
termined that extracellular fluid of cortical slices, as
estimated by the inulin space, equals 22.5% of wet
tissue weight. The slice-to-medium (S/M) concen-
tration ratio was calculated by dividing the tissue
concentration of gentamicin (uncorrected for gen-
tamicin in extracellular fluid), expressed as micro-
grams per gram of wet tissue weight, by the concen-
tration of gentamicin in the medium, expressed as
micrograms per milliliter.
The data in the text, tables, and figures are ex-
pressed as the means SEM. Student's t test was
used for statistical analysis of paired and nonpaired
data. Regression analysis was performed by the
method of least squares.
Results
The renal cortical concentration of 54C-gen-
tamicin determined approximately 160 mm after
starting a constant infusion of 14C-gentamicin was
93 7 jLg/g (N = 7), a value significantly higher (P
<0.01) than that found in the medulla (30 1 tg/g)
and 20-fold greater than the steady-state serum con-
centration of gentamicin (4.8 0.3 tg/ml).
In these rats, the steady-state clearance of inulin
was 2.29 0.19 mllmin, whereas the simultaneous-
ly determined clearance of '4C-gentamicin uncor-
rected for protein binding was 2.13 0.19 mllmin or
92.5 1.4% of the inulin clearance, P < 0.005. Ul-
trafiltration of rat serum containing 14C-gentamicin,
however, indicated that 6.8 1.0% (N = 4) of gen-
tamicin was bound to serum proteins. By equilibri-
um dialysis, 8.2 2.2% (N = 4) of gentamicin was
bound to serum protein. When the clearance of gen-
tamicin was recalculated based on an ultrafilterable
fraction of serum gentamicin of 0.925 (which is the
mean ultrafilterable fraction estimated by the two
methods), the clearance of gentamicin was not sig-
nificantly different from that of inulin (P > 0.4).
Moreover, we discerned no tendency for the frac-
tional excretion of gentamicin to increase between
the first and fourth clearance periods.
Microinjection techniques were used to further
explore the tubular transport of gentamicin. Figure
1 depicts the percent recovery of 3H-gentamicin
from the injected kidney after early proximal, late
proximal proximal distal
(25) (16) (9)
proximal, and early distal tubular microinjections in
group-i rats. The recovery of 14C-inulin was 99.7
0.9%. Percent recovery of 3H-gentamicin after late
proximal tubular injections was significantly greater
than that observed after early proximal tubular in-
jections. Similarly, the percent recovery of 3H-gen-
tamicin after early distal tubular microinjections ex-
ceeded that found after late proximal tubular injec-
tions. The recovery of 3H-gentamicin after early
distal tubular injections was essentially complete.
In none of these experiments was radioactivity re-
covered from the contralateral kidney.
Figure 2 depicts the percent recovery of 3H-gen-
tamicin after early and late proximal tubular injec-
tions performed in the same nephron. In agreement
with the above results, the percent recovery of 3H-
gentamicin after late proximal tubular injections
was significantly greater than that after early proxi-
mal tubular injections. Moreover, the mean percent
recoveries of 66% after early proximal and 83% af-
ter late proximal tubular injections were not signifi-
cantly different from the results obtained when mi-
croinjections were performed in early and late prox-
imal tubular convolutions of random nephrons.
Figure 3 illustrates the fractional and absolute ab-
sorption of 3H-gentamicin along the nephron seg-
ments examined in the group-I experiments. Frac-
100
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69.8 2.7 84.8 3.5 99.4 0.7
40 p < 0.005 P <0.01
Fig. 1. Percent urinary recovery of 3H-gentamicin corrected for
the percent recovery of 4C-inulin after early proximal, late proxi-
mal, and early distal tubular microinjections. The numbers in
parenthesis at the top of the figure signify the number of individ-
ual nephrons injected at each site. The data points represent the
mean value for individual animals. The mean SEM for all ani-
mals is given at the bottom of the figure.
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Fig. 2. Percent urinary recovery of 3H-gentamicin corrected for
the percent recovery of 14C-inulin after early and late proximal
tubular microinjections in the same nephron. Data at the bottom
of the figure represent the mean sai.
tional and absolute absorption of 3H-gentamicin
along the proximal convoluted tubule and ioop of
Henle were essentially identical, whereas beyond
the early distal convoluted tubule, fractional and
absolute absorption of 3H-gentamicin were not dif-
ferent from zero, P> 0.4.
Table 1 summarizes the data of group-2 experi-
ments in which the amount of 5H-gentamicin inject-
ed into early proximal tubular convolutions was in-
creased approximately 15-fold. In these experi-
ments, recovery of 14C-inulin was complete by 12
mm, whereas small amounts of H-gentamicin were
detected still in the urine beyond 24 mm. By 48 mm,
the radioactivity of urine had declined to back-
ground levels. In control nephrons (labeled group A
in Table 1), 88.3 2.6% of the injected 3H-gen-
tamicin was recovered in the urine during the first
24 mm. Over the subsequent 24-mm period, an ad-
ditional 1.4 0.2% of the injected dose was recov-
ered. In a second group of nephrons (labeled group
B in Table 1), injecting approximately 4000 pg of
unlabeled gentamicin 24 mm after the injection of
3H-gentamicin did not augment the urinary recov-
ery of labeled gentamicin during the subsequent 24-
mm period. In no study was radioactivity recovered
from the contralateral kidney during the 48-mm pe-
riod.
Table 2 summarizes the absolute and percent ab-
sorption of 3H-gentamicin after low-dose (132 17
pg) and high-dose (1996 388 pg) microinjections
Table 1. Percent recovery of 3H-gentamicin after early proximal
tubular microinjectionsa
Percent recovery of 3H-gentamicin
0 to 24 mm 24 to 48 mm 0 to 48 mm
GroupA(N 13)
GroupB(N = 8)
88.3 2.6
83.9 1.6
1.4 0.2
1.7 0.3
89.6
85.5
2.7
1.7
P NS NS NS
a Group A nephrons (control) were injected with 3H-gen-
tamicin (1996 388 pg) beginning at time 0. Group B nephrons
also were injected with same dose of 3H-gentamicin at time 0 and
at 24 mm; these nephrons were reinjected at same site with cold
gentamicin (4000 pg); N = number of nephrons; data is ex-
pressed as mean 5EM.
Proximal tubule Loop of Henle Distal nephron
20
fl% Reabsorption
30
cc
Absolute reabsorption .9
.5
5
'10 15
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9-
=9
.0
S 2.0 0
cc
-
.0
as:0 0
14.9 19.8 15.2 19.8 0.6 0.4
3.3 5.2 3.5 5.0 0.7 0.9
NS P<0.001
Fig. 3. Fractional and absolute reabsorption of JJ-gentamicin as afunction of nephron segment. Data at bottom of figure represent the
mean SEM.
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Dose of 3H-gentamicin injected
pg
132 17 1996 388
(N=25) (N=21)
Absolute absorption,pg
Percent absorption
40 5 249 45
P < 0.001
30.1 2.7 13.6 2.6
P < 0.001
into early proximal tubular convolutions. The high-
dose data are derived from all nephrons studied for
48 mm irrespective of whether they were injected
with unlabeled drug (Table 1). A 15-fold increase in
the injected dose of 3H-gentamicin was associated
with a 6-fold rise in the tubular absorption of 3H-
gentamicin. Percent absorption of 3H-gentamicin
declined from 30.1 2.7% of the low dose to 13.6
2.6% of the high dose. These data, illustrated in Fig.
4, indicate a nonlinear relationship between tubular
load and tubular absorption of 3H-gentamicin. The
slope of the regression line for the low dose is signif-
icantly steeper (P < 0.025) than that for the high
dose of 3H-gentamicin.
Peritubular capillary microinjection studies. The
purpose of these experiments was to examine the
1000 2000 3000
possibility that a rapid secretory flux of gentamicin
across tubular epithelium contributes to the urinary
excretion of gentamicin. With this technique, inulin
gains access to the urine only after recirculation and
subsequent glomerular filtration. If 3H-gentarnicin
were to precede the appearance of 14C-inulin in the
urine, it would clearly establish the existence of a
transepithelial secretory flux of gentamicin. As
shown in Fig. 5, 3H-gentamicin and '4C-inulin ap-
peared in the urine simultaneously. The percent re-
covery of 14C-inulin, however, was significantly
greater than that of 3H-gentamicin except at the ini-
tial appearance of both isotopes in the urine when
radioactivity was only slightly above background
and subject to counting error. The profile of cu-
mulative recovery from the contralateral kidney
was nearly identical to that of the injected kidney.
Not only did both isotopes appear simultaneously in
the urine, but the urinary appearance time was pre-
cisely the same as that of the injected kidney. These
findings argue against the possibility of a technical
artifact resulting either from an inadvertent intra-
tubular injection of isotope or from an excessively
rapid injection with retrograde flow to and filtration
of isotope across the glomerular capillaries.
Uptake of gentamicin by renal cortical slices.
Table 3 summarizes the uptake of 14C-gentamicin by
renal cortical slices. In preliminary studies, it was
Table 2. Absolute and percent absorption of 3H-gentamicin after
low-dose and high-dose microinjections into early proximal
tubular convolutions
(A)
y = 9.88 +
r 07750
25
C
U
. 0
50 100 150 200
y71.20+0.09x
1000 r=0.85
P <0.01
500
4000
Injected gentamicin, pg
Fig. 5. Tubular absorption of gentamicin plotted as a function of
dose injected during low-dose (A) and high-dose (B) micro-
injections. The data points represent the mean value for individ-
ual animals. The slopes of the regression lines are significantly
different from each other, P < 0.025.
C
E
C
C
CC
0
0
20
10
0
2 3 4 12 20
Time, mm
Fig. 4. Cumulative percent urinary recoveries of 'W-gentamicin
and '4C-inulin from the ipsilaleral kidney during peritubular cap-
illary microperfusion. The open symbols denote 14C-inulin; the
solid symbols denote 3H-gentamicin.
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established that maximal uptake had occurred with-
in 120 mm of incubation. At a concentration in the
medium of 1.8 x l0- m or 1 (base)/ml, the tis-
sue uptake of 14C-gentamicin averaged 2.9 0.2 g!
g. Accumulation of '4C-gentamicin in cortical slices
increased as the concentration of drug in the medi-
um was raised; the tissue uptake of gentamicin,
however, did not rise in proportion to the increase
in the concentration of gentamicin in the medium.
Thus, the slice-to-medium concentration ratio (SI
M) progressively declined from 3.1 0.2, observed
at the lowest concentration, to 1.5 0.1 (P < 0.001)
observed at highest concentration of gentamicin in
the medium. When slices loaded with 14C-gen-
tamicin were subsequently incubated in gentamicin-
free medium, there was no detectable loss of 14C-
gentamicin from the tissue. Before incubation in
gentamicin-free medium, the S/M ratio was 3.0
0.2; 30 mm after incubation in gentamicin-free me-
dium, the SIM ratio was 2.9 0.2 (N = 4).
The data in Table 4 show that the addition of
probenecid, an organic acid, to the medium to
achieve concentrations 40-fold and 400-fold greater
than that of gentamicin had no inhibitory effect on
the accumulation of '4C-gentamicin by rat renal cor-
tical slices. Similarly, the addition of N1-methyl-
nicotinamide, an organic base, to the medium to
achieve concentrations 20-fold and 2000-fold great-
er than that of gentamicin had no inhibitory effect
on the accumulation of 14C-gentamicin by rat renal
cortical slices. In contrast, when the amino-
glycoside antibiotics netilmicin and tobramycin
were added to the incubation medium, the S/M 14C-
gentamicin concentration ratio was significantly de-
pressed in a dose-dependent manner. Figure 6 de-
o Netilmiciri (N = 5(
• Tobramycin (N = 5)
picts the percent inhibition of 14C-gentamicin accu-
mulation in renal cortical slices by netilmicin and
tobramycin expressed as a function of the concen-
tration of these drugs in the medium. The inhibitory
effect of tobramycin at concentrations of 1.8 x 102
and 1.8 x 10_i m was significantly greater (P <
0.01) than that of netilmicin.
Table 3. Uptake of '4C-gentamicin by rat renal cortical slicesa
'4C-gentamicin concentration in medium
1.8 x 10 mt 3.6 x l0 mrei 3.6 x 10-2 mi 3.6 x 10mM
(N==9) (N=3) (N=3) (N=6)
Tissue 14C-gentamicin, agIg 2.9 0.2 4.0 0.4 36.8 1.9 255.0 18.1
S/M14C-gentamicin 3.1 0.2 2.4 0.2 2.1 0.1 1.5 0.1
a Data are expressed as the mean SEM. S/M is slice-to-medium concentration ratio.
Table 4. Effect of probenecid and N'-methylnicotinamide on the slice/medium (S/M) '4C-gentamicin concentration ratioa
N '-methylnicotinamide
Probenecid concentration in medium concentration in medium
0 7 x lO2mtvt 0.7mM 0 4 x 102mM 4mM
S/M '4C-gentamicin (N = 8) 3.2 0.2 3.3 0.2 3.2 0.2 3.4 0.1 3.3 0.1 3.4 0.1
a Concentration of '4C-gentamicin in medium was 1.8 x 10 mM; data are expressed as mean SEM.
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Fig. 6. Percent inhibition of '4C-gentamicin uptake in renal cor-
tical slices expressed as a function of the concentration of inhib-
itor in the medium. The asterisks denote a significant difference
between netilmicin and tobramycin, P < 0.01.
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Discussion
The results of our studies confirm the observa-
tions of other investigators that gentamicin is accu-
mulated to a greater extent in renal cortex than it is
in medulla [4-6, 8]. Moreover, our data establish
that within 160 mm of starting a constant infusion of
gentamicin the concentration of gentamicin esti-
mated to be within cells or bound to cell membranes
of the cortex exceeded the steady-state serum con-
centration of gentamicin by approximately 20-fold
and exceeded the medullary concentration of gen-
tamicin by more than 3-fold.
Previous investigators have concluded that accu-
mulation of gentamicin in the renal cortex reflects
tubular absorption of filtered gentamicin because
the clearance of gentamicin was significantly less
than the GFR [5, 19, 20]. This conclusion is valid,
however, only if little or no gentamicin is bound to
plasma proteins. The issue of plasma protein bind-
ing of gentamicin remains controversial. Some in-
vestigators have reported no significant plasma pro-
tein binding of this drug [25, 26]; others have report-
ed 20 to 30% of the drug is bound to plasma proteins
[18, 22].
In the present studies, we determined by two
methods that 7.5% of gentamicin was bound to rat
serum proteins. This value is less than that reported
by Meyers et al [22] for binding of gentamicin to
human serum proteins even under conditions of ar-
tificially high calcium and magnesium concentra-
tions and suggests that significant differences may
exist between animal species with respect to protein
binding of this drug. Thus, in the absence of pro-
tein-binding studies, it remains uncertain whether
the gentamicin fractional excretion rate of 82.5% re-
ported by Chiu et al [5] for the dog signifies tubular
absorption of gentarnicin. In our studies, in the rat
the clearance of gentamicin corrected for protein
binding was not significantly different from that of
the inulin clearance. Therefore, the clearance data
provide no evidence for either net tubular absorp-
tion or net tubular secretion of gentamicin.
In contrast to the clearance data, the micro-
injection experiments do support the conclusion
that gentamicin undergoes tubular absorption. After
early and late proximal tubular microinjections, the
urinary recovery of 3H-gentamicin was significantly
less than that of inulin, whereas the recovery of 3H-
gentamicin after early distal tubular microinjections
was not different from that of inulin. These findings
indicate that gentamicin is absorbed along the por-
tion of the proximal convoluted tubule accessible to
micropuncture and along the loop of Henle, where-
as no absorption of gentamicin occurs beyond the
early distal convoluted tubule. Although the seg-
ment(s) of the loop of Henle along which gentamicin
is absorbed cannot be determined from our micro-
puncture experiments, the previously reported find-
ings that gentamicin is transported at least in part by
pinocytosis [9, 11] and that gentamicin-induced
tubular necrosis is confined to the proximal con-
voluted tubule and pars recta [17] suggest that at
least a portion of the gentamicin absorbed along the
loop of Henle reflects uptake by the pars recta. Ac-
cumulation of gentamicin by the pars recta of jux-
tamedullary nephrons might account for the pres-
ence of gentamicin in the medulla.
The absorption of gentamicin along the proximal
tubule and loop of Henle could reflect binding of the
drug to the apical membrane or transmembrane
transport of the drug by various passive or active
processes. Just and Habermann [28] have shown
that aminoglycosides compete with other poly-
cations for receptors on brush border membranes.
Binding of polycations to these receptors is thought
to initiate a sequence of events which culminates in
pinocytosis [29]. Indeed, autoradiographic studies
have localized 3H-gentamicin with apical vesicles of
proximal tubular cells 5 to 10 mm after a pulse injec-
tion of labeled drug [9, 11], and, thus, support the
conclusion that gentamicin is transported, at least in
part, by pinocytosis. Our observation that injecting
a large dose of unlabeled gentamicin did not aug-
ment the urinary recovery of 3H-gentamicin inject-
ed 24 mm earlier indicates that either gentamicin
was tightly bound to brush border membrane recep-
tors or had been transported across the apical mem-
brane, presumably by pinocytosis. Within this con-
text, the decrease in the fractional absorption of
gentamicin observed during the high-dose injections
can be explained by relative saturation of receptors
or encroachment on the maximal transport capacity
of this system which would be limited by the turn-
over rate for new receptors and apical membrane.
Although our data are consistent with tubular ab-
sorption of gentamicin by pinocytosis, they do not
exclude a role for other active or passive transport
mechanisms as well.
Our studies provide no evidence of transtubular
absorption of gentamicin. In none of the micro-
injection experiments was gentamicin recovered
from the urine of the contralateral kidney. We esti-
mate that a transtubular absorptive flux equivalent
to 10% or more of the drugs absorbed in the high-
dose experiments would have been detected by
monitoring the contralateral kidney for radio-
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activity. Thus, if transtubular absorption of gen-
tamicin does occur, the magnitude of the flux is
small compared to the total quantity absorbed from
tubular fluid. It is noteworthy that transcellular
transport by the endocytic pathway of proximal
tubular cells is thought not to occur [29].
Chiu et al [5] have reported that the renal extrac-
tion of gentamicin determined from the arteriove-
nous concentration difference was significantly less
than that of inulin in the dog. Although this observa-
tion is consistent with transtubular absorption of
gentamicin, it may simply indicate that gentamicin
in contrast to inulin is not freely filterable due to
plasma protein binding.
We also failed to detect any evidence of trans-
tubular secretion of gentamicin by the peritubular
capillary microinjection technique. In no experi-
ment did the urinary recovery of 3Hgentamicin pre-
cede that of 1'C-inulin. Although other investigators
have inferred from clearance studies and estimates
of gentamicin binding to serum proteins that net
tubular secretion of gentamicin occurs in man [18],
neither the peritubular capillary microinjection data
nor the clearance data support net tubular secretion
of gentamicin in the rat. We would emphasize, how-
ever, that whereas our data argue against a rapid
transtubular secretory flux of gentamicin, they do
not exclude a slow transtubular secretory flux due
to temporary sequestration of drug in proximal
tubular epithelium after uptake across the basolat-
eral membrane. Thus, it is possible that the pre-
viously documented delayed clearance of gentami-
cm from renal cortex [6] could reflect, in part, a
slow transtubular secretory flux in addition to re-
cycling of absorbed gentamicin across the apical
membrane.
If the renal accumulation of gentamicin in vitro
reflects predominantly the absorption of gentamicin
across the apical membrane of proximal tubular
cells with subsequent sequestration of drug within
lysosomes, then it is somewhat surprising in view of
the apparently large absorptive flux demonstrated
by the microinjection experiments and the absence
of a rapid transtubular secretory flux as shown by
the peritiibular capillary perfusion experiments that
we were unable to detect net tubular absorption
during the steady-state clearance experiments. For
example, if all the drug present in the kidneys at the
end of our clearance studies were derived from
tubular absorption of gentamicin, then a minimal es-
timate of the fractional absorption of gentamicin is
5.4%/mm for the entire course of the experiment.
This estimate is based on the obviously erroneous
assumption that the average filtered load of gen-
tamicin of 10.15 jg!min, determined for the steady-
state period, existed for the entire 160 mm of the
study. A closer approximation, which takes into ac-
count a lower filtered load of gentamicin during the
60-mm equilibration period, yields an average frac-
tional absorption rate of 7.9%/mm. We feel con-
fident that at this rate of absorption our clearance
techniques were sufficiently sensitive to detect at
least some evidence of net absorptive flux. This
analysis holds important implications concerning
the tubular transport of gentamicin and the source
of the cortical concentration of this agent found in
vivo. Whether the failure to detect a net absorptive
flux during the clearance experiments signifies the
development of a secretory flux equal in magnitude
to the absorptive flux or suppression of the absorp-
tive flux possibly as a consequence of having over-
loaded and depleted the apical membrane transport
system remains to be established. In either event it
is difficult to explain the cortical accumulation of
gentamicin solely on the basis of transport across
the apical membrane. These considerations impli-
cate a significant contribution of basolateral mem-
brane transport in the renal tubular accumulation of
gentamicin.
In an attempt to assess basolateral membrane
transport, we examined the uptake of gentamicin by
renal cortical slices. Our results confirm and extend
the observations of Hsu, Kurtz, and Weller [23].
The slice-to-medium gentamicin concentration ratio
was significantly greater than I in all experiments, a
finding which implicates the existence of a mecha-
nism for concentrating gentamicin within renal cor-
tical slices. The observation that the rate of accu-
mulation of gentamicin in cortical slices did not in-
crease in proportion to the concentration of drug in
the medium suggests that this mechanism can be
saturated. Of interest is the finding that no signifi-
cant efflux of gentamicin was detected when slices
loaded with gentamicin were incubated for 30 mm in
gentamicin-free medium. This may indicate that
gentamicin is tightly bound to negatively charged
components of cell membranes or that gentamicin is
transported intracellularly where it binds to intra-
cellular organelles.
Hsu et al [23] reported that gentamicin uptake in
rat renal cortical slices was inhibited by dinitrophe-
nol and by anoxia, findings which are consistent
with active transport of gentamicin but do not ex-
clude a decrease in gentamicin binding to cell mem-
brane receptors. If gentamicin, however, is actively
transported across the basolateral membrane of
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proximal tubular cells, then the failure of high con-
centrations of probenecid or N1-methylnicotin-
amide to depress the tissue accumulation of genta-
micin in vitro argues against a role for either the
organic acid or organic base secretory mechanisms
in this process.
Jerauld and Silverblatt [27] reported that infusing
N1-methylnicotinarnide with gentamicin in a molar
ratio of 40 1 increased the renal clearance of gen-
tamicin and slightly reduced the cortical concentra-
tion of gentamicin in the rat. These investigators
concluded that their data were most consistent with
a slight inhibitory effect of N1-methylnicotinamide
on tubular secretion of gentamicin.
Accumulation of gentamicin in renal cortical
slices was inhibited in a dose-dependent manner by
the aminoglycoside antibiotics netilmicin and tobra-
mycin. These data suggest competition between
aminoglycoside antibiotics for the same receptor(s)
or transport system presumably localized to the
basolateral membrane. That equimolar concentra-
tions of netilmicin and tobramycin inhibited tissue
accumulation of gentamicin by less than 20% im-
plies that the affinity of gentamicin for the receptor
or transport system is significantly greater than that
of either drug, whereas the affinity of tobramycin
for the receptor or transport system appears to be
slightly greater than that of netilmicin.
Just and Habermann [28] examined the relative
binding affinities of aminoglycoside antibiotics for
brush border membrane receptors. Tobramycin ex-
hibited a higher affinity for these receptors than did
gentamicin. This latter finding is somewhat surpris-
ing because we have found that tobramycin accu-
mulates in renal cortex to a far lesser extent than
does gentamicin and, therefore, it introduces some
uncertainty as to the relationship between receptor
binding and transport of these agents. In any event,
the difference between the apparent relative binding
affinities of the aminoglycosides found in our study
and those reported by Just and Habermann [29] sug-
gests that the processes mediating the accumulation
of gentamicin in cortical slices are distinct from
those localized to the brush border membrane.
The results of the cortical slice experiments are
consistent with the interpretation that gentamicin is
transported across the basolateral membrane of
proximal tubular epithelium, although more defini-
tive evidence is required to establish this concept. If
it is assumed that gentamicin does gain access into
proximal tubular cells across the basolateral mem-
brane, what is the contribution of basolateral mem-
brane transport relative to apical membrane trans-
port to the cellular accumulation of gentamicin?
The present experiments were not designed to ad-
dress this question. Autoradiographic studies, how-
ever, suggest that apical membrane transport is
greater than basolateral membrane transport of gen-
tamicin. Within 10 mm after an intravenously inject-
ed pulse of 3H-gentamicin, the labeled drug was lo-
calized over the apical portion of proximal tubular
cells, whereas little or no label was detected over
the basal portion of these cells [9, 11]. Never-
theless, it should be appreciated that autoradiogra-
phy is an insensitive technique for quantitating
transport rate.
In summary, the results of our experiments are
most consistent with the hypothesis that the renal
accumulation of gentamicin reflects transport of
gentamicin across both apical and basolateral mem-
branes of proximal tubular epithelium. The nature
of the transport processes as well as their quan-
titative contribution to the renal accumulation of
gentamicin remain to be defined.
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